Trade Law Daily is a Warren News publication.

FDA Issues Draft Guidance on Distinguishing Device Recalls from Product Enhancements

The Food and Drug Administration said a draft guidance on distinguishing device recalls from product enhancements is now available. The guidance would clarify when a change to a device meets the definition of a recall, and whether FDA should be notified. Device improvements do not necessarily mean old versions of a device need to be recalled, FDA said, but when the new version of a device corrects an identified defect or failure the public should be notified without delay. Comments on the draft guidance are due by May 23.

Sign up for a free preview to unlock the rest of this article

Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.

Email dsmica@fda.hhs.gov for a copy of the draft guidance. Requests should identify the draft guidance as document number 1819.